Have you been diagnosed with bowel cancer and will be having surgery, chemotherapy or radiation therapy in the next 30 days?

A study to assess the effectiveness of a new blood test to detect bowel cancer

The ColoSTAT® test is being developed to provide an alternative option for people to undergo a colorectal cancer (CRC) screening test but for clinical, personal or cultural reasons, are unwilling or unable to use a stool test or are reluctant to undergo more invasive and costly procedures such as colonoscopy and sigmoidoscopy.

ColoSTAT® involves the collection of a blood sample, rather than stool, to assess the presence of components in the blood which, when assessed using a specifically designed algorithm, provide a CRC risk score. The algorithm uses the results from the blood test and incorporates other CRC risk factors, such as family history and lifestyle factors to determine this risk rating.

Anticipated date that enrolment will close: December 2022

Who can take part

  • Participant is diagnosed colonoscopically with colorectal cancer and is progressing to colorectal surgery or neoadjuvant chemo or radiation therapy prior to surgery within 30 days of enrolment.
  • Participant is 40 to <85 years of age inclusive at the time of surgery
  • Participant is able and willing to provide a blood sample prior to surgery.
  • Participant is able and willing to provide stool samples according to written instructions prior to surgery.

What is involved for you

  • medical history
  • weight, height, blood pressure, pulse, heart rate
  • health questionnaires
  • blood samples
  • stool sample
Phase 1
Phase 2
Phase 3
Phase 4

For more information

Quote reference number
Zafirah Khan
(03) 9342 8995
Nicole Tresize
(03) 9342 8411